These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 7422533

  • 1. Effects of oral pentaerythritol tetranitrate in cardiac failure and angina pectoris. Assessment by hemodynamic measurement and exercise capacity.
    Amsterdam EA, Lee G, Awan NA, Low R, Mason DT.
    Nouv Presse Med; 1980 Sep 25; 9(34 Suppl):2443-6. PubMed ID: 7422533
    [Abstract] [Full Text] [Related]

  • 2. [Prolonged hemodynamic effects of pentaerythrityl tetranitrate combined with piridoxylate].
    Baudet M, Hericotte P.
    Sem Hop; 1983 Mar 10; 59(10):683-5. PubMed ID: 6304889
    [Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of pentaerythritol tetranitrate in two doses in patients with stable angina pectoris].
    Kośmicki MA, Malczewska B, Sadowski Z.
    Przegl Lek; 2005 Mar 10; 62(1):8-12. PubMed ID: 16053212
    [Abstract] [Full Text] [Related]

  • 4. [Comparative study of three oral nitrate derivatives. A hemodynamic assessment in 10 patients with chronic heart failure (author's transl)].
    Bory M, Clavier P, Arnoux F, Djiane P, Egre A, Serradimigni A.
    Nouv Presse Med; 1980 Sep 25; 9(34 Suppl):2437-42. PubMed ID: 6775296
    [Abstract] [Full Text] [Related]

  • 5. Antianginal effects of pentaerythritol tetranitrate.
    Arce-Gomez E, Aspe y Rosas J, Alcocer Diaz Barreiro L, Diaz Barreiro AL.
    Nouv Presse Med; 1980 Sep 25; 9(34 Suppl):2487-91. PubMed ID: 6775303
    [Abstract] [Full Text] [Related]

  • 6. The prolonged effect of pentaerythritol tetranitrate on exercise capacity in stable effort angina pectoris.
    Giles TD, Iteld BJ, Quiroz AC, Mautner RK.
    Chest; 1981 Aug 25; 80(2):142-5. PubMed ID: 7018846
    [Abstract] [Full Text] [Related]

  • 7. Sustained beneficial effects of oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.
    Shah PK, Shellock FG, Berman DS, Rubin SA, Singh BN, Swan HJ.
    Nouv Presse Med; 1980 Sep 25; 9(34 Suppl):2447-50. PubMed ID: 7422534
    [Abstract] [Full Text] [Related]

  • 8. [Clinico-functional characteristics of stenocardia and the effectiveness of its treatment with nitrong and erinit].
    Volkov VS, Bratoliubov VP.
    Ter Arkh; 1986 Sep 25; 58(5):124-7. PubMed ID: 3090730
    [Abstract] [Full Text] [Related]

  • 9. Timed-release pentaerythritol tetranitrate and placebo in the management of angina pectoris.
    Cole RE, Goldberg RI.
    Curr Ther Res Clin Exp; 1967 Nov 25; 9(11):551-7. PubMed ID: 4965503
    [No Abstract] [Full Text] [Related]

  • 10. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S.
    Nouv Presse Med; 1980 Sep 25; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [Abstract] [Full Text] [Related]

  • 11. [The hemodynamic profile of pentaerythrityl tetranitrate].
    Engelmann L, Gottschild D.
    Z Gesamte Inn Med; 1981 Apr 01; 36(7):244-6. PubMed ID: 7281826
    [Abstract] [Full Text] [Related]

  • 12. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate.
    Dagenais GR, Mason RE, Friesinger GC, Wender C, Ross RS.
    Johns Hopkins Med J; 1969 Dec 01; 125(6):301-11. PubMed ID: 4905736
    [No Abstract] [Full Text] [Related]

  • 13. Alprenolol alone and in conjunction with pentanitrol in angina pectoris. A double-blind study with exercise tests.
    Hansen PF, Rasmussen PA, Nyberg G.
    Acta Med Scand; 1973 May 01; 193(5):419-24. PubMed ID: 4197873
    [No Abstract] [Full Text] [Related]

  • 14. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K, Bestehorn HP, Roskamm H.
    J Cardiovasc Pharmacol; 1990 May 01; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [Abstract] [Full Text] [Related]

  • 15. Sustained benefits or oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.
    Shellock FG, Shah PK, Berman DS, Rubin SA, Singh BN, Swan HJ.
    Clin Pharmacol Ther; 1980 Oct 01; 28(4):436-40. PubMed ID: 7408403
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of the antiangina pectoris action of 2 coronary vasodilators].
    Arce Gómez E, Alcocer Díaz L, Aspe Rosas JY.
    Arch Inst Cardiol Mex; 1975 Oct 01; 45(1):98-105. PubMed ID: 1093498
    [Abstract] [Full Text] [Related]

  • 17. [Clinical usefulness of high-dose oral nitroglycerin in patients with stable angina pectoris].
    Kośmicki MA, Skorykow-Sapińska A, Sadowski Z.
    Wiad Lek; 2003 Oct 01; 56(7-8):313-8. PubMed ID: 14969156
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of coronary angina. Use of a delayed-action nitrate derivative].
    Giard.
    J Sci Med Lille; 1972 Nov 01; 90(11):407-10. PubMed ID: 4650213
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of prolonged-action pentaerythritol treatment in angina pectoris. Study base on its effects on the modifications of the electrocardiogram induced by the effort test].
    Vedoya R, Nessi CT, Papakis ME, Gaguine S.
    Prensa Med Argent; 1966 Jul 08; 53(27):1468-79. PubMed ID: 5990480
    [No Abstract] [Full Text] [Related]

  • 20. Nitroglycerin prophylaxis in angina pectoris. Effect of sustained release nitroglycerin capsules on anginal frequency and exercise capacity.
    Davidov ME, Green AM.
    Nouv Presse Med; 1980 Sep 25; 9(34 Suppl):2473-7. PubMed ID: 6775301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.